Related Experiment Video
Updated: Aug 5, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Genetic Susceptibility to Nephrolithiasis: A Genome-Phenome Approach with Polygenic Risk Score Analysis
Chun-Yi Chen1, Sunyeop Lee2, Chi-Maw Lin3,4
1College of Medicine, National Taiwan University, Taipei, Taiwan.
This study identifies key genetic factors for kidney stone disease (KSD) in East Asians. A polygenic risk score (PRS) shows potential for predicting KSD risk, highlighting immune dysregulation
Area of Science:
- Genetics
- Genomics
- Epidemiology
Background:
- Kidney stone disease (KSD) is multifactorial with a poorly understood genetic basis in East Asian populations.
- Elucidating genetic factors is crucial for understanding KSD pathogenesis in this demographic.
Purpose of the Study:
- To comprehensively identify genetic factors associated with KSD in Taiwanese Han Chinese individuals.
- To validate findings using national health data and assess the predictive utility of a polygenic risk score (PRS).
Main Methods:
- Genome-wide association study (GWAS) on 108,483 participants (7,635 with KSD).
- Phenome-wide association study (PheWAS) using the National Health Insurance Research Database.
- Polygenic risk score (PRS) development and evaluation.
Main Results:
- Significant KSD associations found at rs1481012 (chromosome 4) and rs12872074 (chromosome 13).
- Identified genes include ABCG2, DGKH, and the novel locus PKD2.
- PheWAS confirmed variant associations with kidney calculus and related phenotypes; PRS achieved an AUC of 0.97.
Conclusions:
- This study reveals significant genetic contributors to KSD in an East Asian population.
- National health databases aid in validating findings and uncovering novel disease correlations, suggesting immune dysregulation's role.
- PRS demonstrates potential for clinical application in KSD risk prediction, pending further validation.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Polygenic Traits
Polygenic Traits
Urinary Tract Calculi I: Introduction